{"id":1630,"date":"2024-03-19T09:11:56","date_gmt":"2024-03-19T13:11:56","guid":{"rendered":"https:\/\/piramalcriticalcare.com\/uk\/?page_id=1630"},"modified":"2024-03-19T10:22:43","modified_gmt":"2024-03-19T14:22:43","slug":"summary-of-product-characteristics-and-patient-information-leaflet","status":"publish","type":"page","link":"https:\/\/piramalcriticalcare.com\/uk\/products\/ropivacaine-readyfusor\/summary-of-product-characteristics-and-patient-information-leaflet\/","title":{"rendered":"Summary of Product Characteristics and Patient Information Leaflet"},"content":{"rendered":"\n<p>&nbsp;Ropivacaine is indicated for acute, postoperative pain management in adults.<\/p>\n\n\n\n<p>&nbsp;Ropivacaine is used:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>To maintain a continuous peripheral nerve block via a continuous infusion.&nbsp;<\/li>\n\n\n\n<li>For continuous wound infiltration.&nbsp;<\/li>\n<\/ul>\n\n\n\n<p>For ReadyfusOR\u2122 Summary of Product Characteristics, please <a href=\"https:\/\/piramalcriticalcare.com\/uk\/wp-content\/uploads\/sites\/3\/2024\/03\/spc-uk-ropivacaine-gen2-22-10.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">click here<\/a>.<\/p>\n\n\n\n<p>For ReadyfusOR\u2122 Patient Information Leaflet, please <a href=\"https:\/\/piramalcriticalcare.com\/uk\/wp-content\/uploads\/sites\/3\/2024\/03\/pl-uk-ropivacaine-gen2-22-10.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">click here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp;Ropivacaine is indicated for acute, postoperative pain management in adults. &nbsp;Ropivacaine is used:&nbsp; For ReadyfusOR\u2122 Summary of Product Characteristics, please click here. For ReadyfusOR\u2122 Patient Information Leaflet, please click here.<\/p>\n","protected":false},"author":19,"featured_media":0,"parent":1626,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1630","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/pages\/1630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/comments?post=1630"}],"version-history":[{"count":0,"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/pages\/1630\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/pages\/1626"}],"wp:attachment":[{"href":"https:\/\/piramalcriticalcare.com\/uk\/wp-json\/wp\/v2\/media?parent=1630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}